Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by StockinFockeron May 17, 2015 5:07pm
147 Views
Post# 23737604

RE:don't believe the hype

RE:don't believe the hype
Well Chefboy, Vanc has already begun taking delivery of generic drugs from manufacturers - if you can stop laughing long enough you may want to read this from Vanc's May 4, 2015 NR:

"Further to the press release of January 14, 2015 the Company is pleased to report that it has began taking delivery of initial generic drug inventory from purchase orders placed with manufacturers earlier this year. 'We are happy to advise that our product inventory build - up is on schedule and we will be ready to ship some of these products to customers towards the end of Q2 - 2015,' said Nayyar."

ref:
https://www.vancpharm.com/wp-content/uploads/2015/05/2015-05-04_NPH_NR.pdf

So Chefboy, you stated: "Vanc has yet to produce 1 drug". As stated in the NR above Vanc has already begun taking delivery of their initial drug inventory from the manufacturers. So does that or does that not that fit into your definition of "produce"? That's about as close to "producing" drugs as Vanc is going to get before beginning actual sales and delivery shortly....

Chefboy69 wrote: this is being proped up by a few players

and I agree with therookie87

this is going lower FIRST before it goes HIGHER

what most don't understand and what gets me laughing is

"The Company plans to manufacture its products at four certified GMP pharmaceuticals factories in Canada, India and China. These US FDA approved plants are capable of manufacturing a wide range of Generic Pharmaceuticals and OTC Health care products at these facilities, under the VANCPHARM label. VANC Pharmaceuticals has presence through affiliated companies to source products from China, and India.



Vanc has yet to produce 1 drug






Bullboard Posts